1/91
Comprehensive vocabulary flashcards covering the pathophysiology, clinical presentations, diagnostic findings, and management of microcytic, macrocytic, normocytic, and hemolytic anemias.
Anemia
A decrease in circulating hemoglobin concentration below the expected reference range, with the primary clinical consequence of reduced oxygen-carrying capacity to tissues.
Diagnostic Hemoglobin Cutoffs for Anemia
A circulating hemoglobin concentration of <13g/dL in adult males and <12g/dL in non-pregnant adult females.
Mean Corpuscular Volume (MCV)
An erythrocyte index that reflects average red blood cell size; classified as microcytic (<80fL), normocytic (80−100fL), or macrocytic (>100fL).
Mean Corpuscular Hemoglobin Concentration (MCHC)
An erythrocyte index reflecting hemoglobin concentration per unit volume of packed red cells; classified as hypochromic (<32g/dL), normochromic (32−36g/dL), or hyperchromic (>36g/dL).
Reticulocyte Count
The percentage of immature circulating red blood cells (normal range: 0.5−2.5%); an increased count indicates an appropriate bone marrow response to blood loss or hemolysis, whereas an inadequate count reflects impaired or ineffective erythropoiesis.
Microcytic Anemia
A category of anemia characterized by an MCV <80fL, arising from impaired hemoglobin synthesis due to iron deficiency, chronic disease/inflammation, thalassemia, or sideroblastic defects.
Pica
The compulsive craving and consumption of non-nutritive substances, particularly ice (pagophagia), strongly suggestive of iron deficiency.

Koilonychia
Abnormal spoon-shaped deformation of the fingernails associated with chronic iron deficiency anemia.

Angular Cheilitis
Inflammation, erythema, and painful fissuring at one or both labial commissures of the mouth, classically seen in nutritional deficiencies including iron, vitamin B12, or folate.

Glossitis
Inflammation resulting in a smooth or beefy-red sore tongue, characteristic of iron deficiency, folate deficiency, or vitamin B12 deficiency.
Ferritin
The primary intracellular iron-storage protein; a decreased serum level is the most sensitive test and pathognomonic for iron deficiency anemia.
Total Iron-Binding Capacity (TIBC)
A laboratory measurement of transferrin's capacity to bind iron; characteristically increased in iron deficiency anemia and decreased in anemia of chronic inflammation.
Ferrous Sulfate
An inexpensive, first-line oral iron salt dosed as 325mg once daily or every other day, delivering approximately 65mg of elemental iron.
Anemia of Chronic Disease / Chronic Inflammation
A functional iron deficiency driven by inflammatory cytokines (notably IL-6) that increase hepcidin production, leading to iron sequestration within macrophages and reduced availability for erythropoiesis despite normal or increased ferritin.
Hepcidin
An acute-phase reactant peptide produced by the liver that binds ferroportin and induces its degradation, blocking iron release from macrophages and suppressing intestinal iron absorption.

Sideroblastic Anemia
A disorder caused by a defect in heme synthesis that results in pathologic accumulation of iron in erythroblast mitochondria, forming characteristic ring sideroblasts around erythroid nuclei in the bone marrow.

Burton's Line
A thin, bluish-black line along the dental-gingival margin caused by lead deposition, observed in patients with substantial or prolonged lead exposure.
Basophilic Stippling
The presence of fine or coarse ribosomal RNA granules throughout erythrocytes on peripheral blood smear, classically seen in lead poisoning, sideroblastic anemia, and thalassemias.

Lead Lines
Transverse bands of increased radiodensity appearing at the metaphyseal growth plates (particularly the knee and wrist) on plain radiographs of children with lead toxicity.
Thalassemia
A group of inherited, quantitative hemoglobin disorders caused by reduced or absent synthesis of one or more globin polypeptide chains, leading to unbalanced chain precipitation, ineffective erythropoiesis, and microcytic hemolysis.
Hemoglobin H (HbH) Disease
An alpha-thalassemia phenotype resulting from the deletion of three alpha-globin genes, characterized by the formation of unstable beta-chain tetramers (β4), symptomatic hemolytic anemia, splenomegaly, and Heinz bodies.
Hydrops Fetalis (Hemoglobin Barts)
A fatal four-gene deletion alpha-thalassemia in which gamma-globin chains form tetramers (γ4) with extreme oxygen affinity, causing profound intrauterine tissue hypoxia and fetal demise.
Beta Thalassemia Minor (Trait)
A heterozygous condition with one defective beta-globin gene, characterized clinically by asymptomatic mild microcytic anemia, normal iron studies, and elevated HbA2 on hemoglobin electrophoresis.
Beta Thalassemia Major (Cooley's Anemia)
A homozygous beta-globin mutation leading to absent or severely deficient beta chains, presenting after 6months of age as severe chronic hemolytic anemia (Hgb<7g/dL), hepatosplenomegaly, and skeletal deformity.

Chipmunk Facies and Frontal Bossing
Facial and cranial skeletal deformities caused by severe chronic bone marrow expansion in untreated or undertreated beta-thalassemia major.

"Hair on End" Sign
A characteristic diploic skull x-ray appearance caused by extensive compensatory intramedullary erythroid hyperplasia in beta-thalassemia major.
Megaloblastic Anemia
A subcategory of macrocytic anemia (MCV>100fL) caused by impaired DNA synthesis, morphologically identified on peripheral smear by macro-ovalocytes and hypersegmented neutrophils.
Hypersegmented Neutrophils
Neutrophils exhibiting ≥6 nuclear lobes in a single cell or an increased frequency of cells with ≥5 lobes, diagnostic of megaloblastic maturation arrest.
Pernicious Anemia
An autoimmune etiology of vitamin B12 deficiency caused by autoantibody-mediated destruction of gastric parietal cells, leading to loss of intrinsic factor secretion and impaired ileal cobalamin absorption.
Anti-Intrinsic Factor Antibodies
Serologic autoantibodies that are highly specific for the diagnosis of pernicious anemia.
Methylmalonic Acid (MMA)
A biochemical metabolite elevated exclusively in vitamin B12 deficiency due to blocked isomerization to succinyl-CoA, remaining normal in pure folate deficiency.
Folate Deficiency
A nutritional megaloblastic macrocytic anemia caused by inadequate dietary intake, malabsorption, or increased demand (e.g., pregnancy), presenting with elevated homocysteine, normal MMA, and an absence of neurologic deficits.
Haptoglobin
A liver-synthesized plasma protein that scavenges and binds circulating free hemoglobin; a depleted serum level serves as a sensitive marker of ongoing hemolysis.
Hereditary Spherocytosis
An autosomal dominant RBC membrane disorder caused by ankyrin or spectrin defects, resulting in spherical, non-deformable erythrocytes that undergo extravascular splenic destruction; characterized by spherocytes, elevated MCHC, and a negative DAT.
Eosin-5-Maleimide (EMA) Binding Test
The most sensitive and specific confirmatory flow-cytometric test for diagnosing hereditary spherocytosis.
Paroxysmal Nocturnal Hemoglobinuria (PNH)
An acquired stem cell mutation affecting GPI-anchor synthesis, leading to the absence of protective complement-regulatory surface proteins (CD55 and CD59), complement-mediated intravascular hemolysis, and atypical venous thrombosis.
Eculizumab
A recombinant monoclonal antibody complement inhibitor targeting C5 that prevents membrane attack complex (MAC) assembly in paroxysmal nocturnal hemoglobinuria; requires prior meningococcal vaccination due to infection risk.
Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency
An X-linked enzymopathy characterized by impaired NADPH generation, glutathione depletion, and vulnerability of red blood cells to episodic oxidative hemolysis triggered by infections, fava beans, or oxidant medications.
Heinz Bodies
Insoluble inclusions composed of oxidized, denatured hemoglobin that precipitate within red blood cells under oxidative stress in G6PD deficiency and Hemoglobin H disease.
Bite Cells
Abnormally shaped erythrocytes produced when splenic macrophages pluck out rigid Heinz body inclusions from circulating RBC membranes in patients with G6PD deficiency.
Sickle Cell Disease (SCD)
An autosomal recessive hemoglobinopathy resulting from a point mutation in the beta-globin gene producing hemoglobin S (HbS), which polymerizes during deoxygenation to cause cellular distortion, hemolysis, and microvascular vaso-occlusion.
Dactylitis
Painful microvascular vaso-occlusive swelling of the hands and feet ("sausage digits") that serves as an early clinical hallmark of sickle cell anemia in infants around 6months of age.
Acute Chest Syndrome
A life-threatening medical emergency in sickle cell disease defined by a new pulmonary infiltrate on chest radiography combined with fever, chest pain, tachypnea, dyspnea, or hypoxemia.
Splenic Sequestration Crisis
A medical emergency in young children with sickle cell disease characterized by sudden trapping of red blood cells in the spleen, resulting in rapid splenic enlargement, hypovolemia, marked hemoglobin drop (≥2g/dL), and reticulocytosis.
Transient Aplastic Crisis
A sudden, profound cessation of red blood cell production triggered by Parvovirus B19 infection of erythroid precursors in patients with chronic hemolytic anemias, presenting as a precipitous drop in hemoglobin and a suppressed reticulocyte count.
Hydroxyurea
A disease-modifying oral medication for sickle cell disease that stimulates fetal hemoglobin (HbF) production, thereby preventing HbS polymerization, improving cellular hydration, and reducing the frequency of painful vaso-occlusive crises.
Aplastic Anemia
A life-threatening bone marrow failure disorder characterized by peripheral blood pancytopenia, an inappropriately low reticulocyte response, and profound bone marrow hypocellularity with fatty replacement.
Warm Autoimmune Hemolytic Anemia (Warm AIHA)
An acquired autoimmune condition mediated by IgG antibodies that react with RBCs at body temperature (37∘C), resulting in extravascular splenic macrophage phagocytosis and a positive direct antiglobulin test (DAT) for IgG and/or C3.
Cold Agglutinin Disease
An autoimmune hemolytic anemia driven by IgM antibodies that bind erythrocytes at cooler temperatures (<37∘C), triggering complement fixation, hepatic clearance, a positive DAT for C3 only, and cold-induced acrocyanosis.
Hereditary Hemochromatosis
An autosomal recessive disorder associated with HFE gene mutations that causes pathologically low hepcidin levels, uncontrolled ferroportin-mediated intestinal iron absorption, and toxic multi-organ iron accumulation in the liver, pancreas, heart, and joints.
Therapeutic Phlebotomy
The first-line therapy for hereditary hemochromatosis, performed every 1−2weeks until serum ferritin decreases to 50μg/L, followed by maintenance phlebotomies to sustain ferritin levels between 50−100μg/L.
Unfractionated Heparin (UFH) Mechanism
Potentiates antithrombin to accelerate the inhibition of both factor IIa (thrombin) and factor Xa, preventing the conversion of fibrinogen to fibrin.
Low-Molecular-Weight Heparin (LMWH) Mechanism
Binds to antithrombin to predominantly inhibit factor Xa, with significantly less activity against factor IIa (thrombin).
Warfarin Mechanism of Action
Inhibits vitamin K epoxide reductase (VKORC1), blocking the regeneration of active vitamin K and reducing hepatic synthesis of factors II, VII, IX, and X, as well as proteins C and S.
Direct Oral Factor Xa Inhibitors
Oral anticoagulants such as apixaban and rivaroxaban that directly and selectively bind to and inhibit factor Xa without requiring antithrombin as a cofactor.
Protamine Sulfate
A positively charged reversal agent that binds negatively charged heparin molecules to completely neutralize unfractionated heparin and partially reverse low-molecular-weight heparin.
Four-Factor Prothrombin Complex Concentrate (4F-PCC)
An urgent reversal product containing concentrated clotting factors II, VII, IX, and X, along with proteins C and S, primarily indicated for life-threatening bleeding induced by warfarin.
Polycythemia Vera (PV)
A chronic myeloproliferative neoplasm characterized by autonomous overproduction of red blood cells driven almost universally by the JAK2 mutation, accompanied by low serum erythropoietin.
Aquagenic Pruritus
Intense generalized itching without an evident primary rash occurring after contact with warm water, caused by basophil histamine release in polycythemia vera.
Essential Thrombocythemia (ET)
A chronic myeloproliferative disorder marked by sustained megakaryocyte proliferation, autonomous platelet overproduction (>450,000/μL), and clinical risks of both thrombosis and paradoxical bleeding.
Primary Myelofibrosis (PMF) Blood Smear Hallmark
The presence of dacrocytes (teardrop-shaped red blood cells) and a leukoerythroblastic picture containing immature granulocytes and nucleated red cells due to extramedullary hematopoiesis.
Myelodysplastic Syndrome (MDS)
A group of clonal preleukemic hematopoietic stem cell disorders characterized by ineffective hematopoiesis, peripheral cytopenias, morphologic dysplasia in bone marrow precursors, and risk of progression to acute myeloid leukemia.
Hodgkin Lymphoma Pathognomonic Histology
Reed-Sternberg cells, which appear as large, binucleated or multinucleated B-lineage cells with prominent inclusion-like nucleoli exhibiting an 'owl-eyes' appearance surrounded by reactive inflammatory infiltrates.
Diffuse Large B-Cell Lymphoma (DLBCL)
The most common histologic subtype of non-Hodgkin lymphoma in adults, characterized by an aggressive clinical course, rapidly enlarging nodal or extranodal masses, and high potential for cure with chemoimmunotherapy.
Burkitt Lymphoma
A highly aggressive high-grade B-cell non-Hodgkin lymphoma associated with Epstein-Barr virus and c-MYC translocations, carrying an exceptionally high risk of spontaneous tumor lysis syndrome.
Multiple Myeloma Clinical Pentad (CRAB)
End-organ damage defined by hypercalcemia, renal insufficiency, anemia, and lytic bone lesions resulting from clonal neoplastic plasma cell proliferation and marrow infiltration.
Monoclonal Gammopathy of Undetermined Significance (MGUS)
An asymptomatic premalignant plasma cell proliferative state defined by a serum monoclonal protein spike, <10% marrow plasma cells, and the complete absence of CRAB end-organ damage.
Waldenström Macroglobulinemia
A lymphoplasmacytic lymphoma characterized by excessive monoclonal IgM secretion that produces hyperviscosity syndrome, hepatosplenomegaly, and cytopenias without lytic bone lesions.
Tumor Lysis Syndrome Metabolic Abnormalities
Massive intracellular electrolyte release from rapid neoplastic cell breakdown causing hyperkalemia, hyperphosphatemia, hyperuricemia, and secondary hypocalcemia that precipitate acute renal failure and cardiac arrhythmias.
Febrile Neutropenia Diagnostic Criteria
A single oral temperature of ≥38.3∘C (101∘F) or a sustained temperature of ≥38.0∘C (100.4∘F) for over one hour in a patient with an absolute neutrophil count <500cells/μL.
Leukostasis Syndrome
A medical emergency caused by hyperleukocytosis (WBC>100,000/μL) where rigid, non-deformable myeloblasts plug the microvasculature, classically manifesting as respiratory distress and neurologic deficits.
Acute Myeloid Leukemia (AML) Diagnostic Hallmark
Bone marrow or peripheral blood demonstrating ≥20% myeloblasts, frequently containing pathognomonic Auer rods (crystalline inclusions of aggregated cytoplasmic peroxidase-positive granules).
Acute Lymphoblastic Leukemia (ALL)
The most common pediatric malignancy, characterized by uncontrolled bone marrow proliferation of immature B- or T-lymphoblasts that suppress normal hematopoiesis and can infiltrate the central nervous system and testes.
Chronic Myeloid Leukemia (CML) Cytogenetic Hallmark
The Philadelphia chromosome, generated by the t(9;22) reciprocal translocation that creates the BCR::ABL1 fusion oncogene encoding a constitutively active tyrosine kinase.
Chronic Lymphocytic Leukemia (CLL) Diagnostic Smear Finding
Isolated absolute lymphocytosis (>5,000/μL) with mature-appearing, fragile lymphocytes that readily rupture during glass slide preparation to produce pathognomonic 'smudge cells'.
Immune Thrombocytopenia (ITP) Pathophysiology
Autoantibodies directed against platelet surface glycoprotein IIb/IIIa complexes trigger splenic macrophage phagocytosis, producing isolated thrombocytopenia with normal coagulation studies and absent splenomegaly.
Thrombotic Thrombocytopenic Purpura (TTP) Pathophysiology
Severe deficiency or autoantibody inhibition of the zinc metalloprotease ADAMTS-13, preventing cleavage of ultra-large von Willebrand factor multimers and causing widespread microvascular platelet thrombosis and microangiopathic hemolytic anemia.
Hemolytic Uremic Syndrome (HUS) Typical Presentation
An acute triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure, characteristically triggered in young children following prodromal bloody diarrhea caused by Shiga-toxin-producing Escherichia coli.
Factor V Leiden Mutation
The most common inherited thrombophilia, caused by a point mutation that renders factor Va resistant to proteolytic cleavage and inactivation by activated protein C.
Heparin-Induced Thrombocytopenia (HIT) Pathophysiology
An immune-mediated prothrombotic state caused by IgG autoantibodies targeting complexes of platelet factor 4 (PF4) and heparin, inducing platelet activation, aggregation, consumption, and high risk of venous and arterial thrombosis.
Hemophilia A
An X-linked recessive bleeding disorder caused by deficiency or dysfunction of clotting factor VIII, typically presenting with recurrent hemarthrosis, deep muscle hematomas, and an isolated prolonged aPTT.
Hemophilia B (Christmas Disease)
An X-linked recessive coagulopathy caused by a deficiency of vitamin K-dependent factor IX, presenting with identical clinical manifestations and coagulation assays as factor VIII deficiency.
von Willebrand Disease (VWD)
The most common inherited bleeding diathesis, characterized by quantitative or functional defects in VWF that impair platelet adhesion to the vascular subendothelium and reduce secondary carrier stabilization of factor VIII.
Disseminated Intravascular Coagulation (DIC) Laboratory Pattern
Systemic activation of hemostasis resulting in severe thrombocytopenia, prolonged PT and aPTT, marked hypofibrinogenemia from factor consumption, elevated D-dimer from widespread fibrinolysis, and schistocytes on smear.
TNM Staging System
A standardized solid-tumor staging framework evaluating primary tumor dimensions and local invasion (T), regional lymph node involvement (N), and the presence or absence of distant metastasis (M).
Malignant Spinal Cord Compression Clinical Hallmark
Progressive, non-mechanical back pain in a patient with known cancer that worsens when supine or with Valsalva maneuvers, requiring emergent whole-spine MRI and high-dose intravenous dexamethasone.
Superior Vena Cava (SVC) Syndrome
Vascular obstruction of cranial and upper extremity venous return, most commonly caused by mediastinal malignancies such as small cell lung carcinoma or lymphoma, producing facial plethora, neck vein distention, and dyspnea.
Hypercalcemia of Malignancy Primary Mechanism
Tumor-mediated secretion of parathyroid hormone-related peptide (PTHrP) or direct osteolytic skeletal destruction, presenting with confusion, bone pain, constipation, polyuria, and shortened QT interval.
Acute Hemolytic Transfusion Reaction (AHTR)
A life-threatening complication typically caused by ABO-incompatible red blood cell transfusion, where recipient preformed IgM antibodies fix complement to cause catastrophic intravascular hemolysis, hypotension, hemoglobinuria, and DIC.
Transfusion-Related Acute Lung Injury (TRALI)
Donor anti-HLA or anti-HNA antibodies activating recipient pulmonary capillary neutrophils, causing capillary leak, hypoxemia, fever, and noncardiogenic bilateral pulmonary edema without volume overload.
Transfusion-Associated Circulatory Overload (TACO)
A hydrostatic, cardiogenic pulmonary edema occurring when rapid or massive blood product infusion exceeds cardiac capacity, characterized by hypertension, elevated brain natriuretic peptide, and positive clinical response to loop diuretics.
Febrile Nonhemolytic Transfusion Reaction (FNHTR)
A benign post-transfusion temperature elevation of ≥1∘C (to at least 38.0∘C) driven by cytokines accumulated in donor leukocyte-rich plasma during storage, preventable with prestorage leukoreduction.